System-level modeling and simulation of the cell culture microfluidic biochip ProCell by Minhass, Wajid Hassan et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
System-level modeling and simulation of the cell culture microfluidic biochip ProCell
Minhass, Wajid Hassan; Pop, Paul; Madsen, Jan; Hemmingsen, Mette; Dufva, Martin
Published in:
2010 Symposium on  Design Test Integration and Packaging of MEMS/MOEMS
Publication date:
2010
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Minhass, W. H., Pop, P., Madsen, J., Hemmingsen, M., & Dufva, M. (2010). System-level modeling and
simulation of the cell culture microfluidic biochip ProCell. In 2010 Symposium on  Design Test Integration and
Packaging of MEMS/MOEMS (pp. 91-98). IEEE.
 5-7 May 2010, Seville, Spain 
 
©EDA Publishing/DTIP 2010 ISBN: 978-2-35500-011-9 
System-Level Modeling and Simulation of the  
Cell Culture Microfluidic Biochip ProCell 
 
Wajid Hassan Minhass†, Paul Pop†, Jan Madsen†, Mette Hemmingsen‡, Martin Dufva‡  
†Department of Informatics and Mathematical Modeling 
‡Department of Micro- and Nanotechnology 
Technical University of Denmark, DK-2800 Kgs. Lyngby 
email: whmi@imm.dtu.dk  
 
Abstract-Microfluidic biochips offer a promising alternative 
to a conventional biochemical laboratory. There are two 
technologies for the microfluidic biochips: droplet-based and 
flow-based. In this paper we are interested in flow-based 
microfluidic biochips, where the liquid flows continuously 
through pre-defined micro-channels using valves and pumps. 
We present an approach to the system-level modeling and 
simulation of a cell culture microfluidic biochip called ProCell, 
Programmable Cell Culture Chip. ProCell contains a cell 
culture chamber, which is envisioned to run 256 simultaneous 
experiments (viewed as a 16 x 16 matrix). We use an inverted 
fluorescence microscope to observe the experiments in real-
time, allowing kinetic data analysis. We are able to automati-
cally adjust the current experimental setup thus allowing, for 
the first time, conditional experiments. We propose a biochip 
architecture model and a comprehensive fault model that 
captures permanent faults occurring during chip operation. 
Using the proposed modeling and simulation framework, we 
perform an architectural level evaluation of two cell culture 
chamber implementations. A qualitative success metric is also 
proposed to evaluate chip performance in the presence of 
partial failures. Our results show that significant improve-
ments in efficiency can be obtained using redundancy, provid-
ing improved chances to complete an experiment even in the 
presence of faults. This decreases the experiment repetition 
rate while increasing system productivity, saving time and 
reducing costs. 
I.  INTRODUCTION 
During the last decade, microfluidic biochips have be-
come an actively researched area [1]. By miniaturizing the 
macroscopic chemical and biological processes to a sub-
millimeter scale, microfluidic systems enable the integration 
of various assays onto a single chip. The technology is 
referred to as lab-on-a-chip (LoC), as it offers a promising 
alternative to a conventional biochemical laboratory. In 
addition to the reduced geometrical dimensions, this minia-
turization also results in reduced required reagent volumes, 
saving material costs. Moreover, because of the homogene-
ous reaction conditions at the micro level, microfluidic-
based systems provide results of enhanced precision com-
pared to the conventional biochemical analyzers [2]. 1 
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There are two technologies for the microfluidic biochips: 
droplet-based [4] and flow-based [7]. Droplet-based bio-
chips, also referred to as digital biochips, deal with discrete 
droplets on a two-dimensional electrode array and have so 
far been the focus of attention of the design automation 
community [5] [6]. In flow-based microfluidic biochips, the 
liquid flows continuously through pre-defined micro-
channels using valves and pumps [7]. These flow-based 
biochips are fabricated using multilayer soft lithography 
techniques. Although the soft lithography technology has 
advanced faster than Moore’s law [9], the design methodol-
ogy of these biochips is still based on the bottom-up custo-
mized approach involving multiple manual steps with 
minimum design automation. Each new chip is designed by 
creating and connecting the on-chip components based on 
the precise steps of a specific assay [14], thus the chips are 
termed as “Full Custom” biochips. 
As the designs become larger and more complex, the cur-
rent bottom-up full-custom design approach will not scale to 
the new designs, widening the gap between the manufactur-
ing technology capability and the achieved design complex-
ity.  New top-down computer-aided design tools are re-
quired, which can offer the same level of support as the one 
taken for granted currently in the semiconductor industry 
[10]. 
As a first step, we need to model the biochemical applica-
tions separately from the architecture. Thies et al. [12] 
propose a software system called BioStream with two levels 
of abstraction for describing biological assays. The first 
layer consists of a BioStream library, which is used to write 
a program for describing the assay. The second abstraction 
layer, a fluidic instruction set architecture (ISA), interfaces 
the first level with the underlying biochip architecture. 
Their work serves as a first step for decoupling the architec-
ture from the assays.  
Amin et al. [11] propose a general-purpose microfluidic 
architecture called AquaCore and an instruction set (consist-
ing of instructions, such as, <input id2, id1>and <mix id, 
time> where id1 is an input port, id2 is a reservoir and id is 
the mixer) to be implemented on this architecture. Aqua-
Core can be programmed to run any assay, and is thus 
termed as programmable LoC (PLoC). Although such a 
general-purpose PLoC has the obvious advantage of fast 
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turnaround time and lower cost (due to production in larger 
quantities compared to the full custom biochips), it has a 
key concern of reliability (valves operate reliably only for a 
few thousands of actuations), as reported in the paper. 
Furthermore, considering the vast variety in the biochemical 
applications in terms of the biochip architectural require-
ments, it is not possible to run all these applications on one 
architecture. Even if it is assumed that all these applications 
can be run by a generic PLoC, it is very difficult to achieve 
a reasonably high efficiency for all these applications from 
the same architecture.  
Considering the above facts and the low cost of the manu-
facturing process (soft lithography) [8] for the flow-based 
microfluidic biochips, it is more suitable to develop applica-
tion-specific architectures providing a compromise between 
full custom and general-purpose architectures. These appli-
cation-specific programmable LoC (ASPLoC) can be tai-
lored to provide a higher efficiency for a specific set of 
applications bringing it closer to the full custom biochips, 
while retaining the advantages of lower cost and flexibility 
of the general purpose PLoCs.  
Modeling and simulation of the LoC systems are impera-
tive for quickly evaluating design decisions without build-
ing costly prototypes. The simulations can be carried out at 
different levels of abstraction. Chakrabarty et al. [10] pro-
pose hierarchical modeling and simulation framework for 
the LoC systems, from the component-level to the system-
level. The system level involves system performance mod-
eling and behavioral simulation of the system operation. 
The system model needs to be complemented by component 
models in order to characterize the individual microfluidic 
component behavior, and to emphasize the physical proper-
ties and the relationships at the circuit level.  Wang et al. 
[18] present a schematic-based approach to model and 
simulate the LoC systems using theoretical microfluidic 
models for the components. They use parameterized and 
closed-form models of the LoC elements to perform both 
DC and transient analysis of the chip. Using the analyses, 
they propose to capture the influence of topology, element 
sizes, and material properties on the biochip performance. 
Amin et al. [13] propose computer-aided design support 
methods for the microfluidic biochips at the physical design 
level. They propose methods to automatically infer the 
control valve placement, reducing the number of control 
lines needed to drive the valves and for routing these valves 
to the control ports. 
In this paper, we present an approach for the high level 
modeling and simulation of a cell culture microfluidic 
biochip called ProCell, Programmable Cell Culture Chip 
[15]. ProCell is envisioned to run up to 256 experiments 
simultaneously. We use an inverted fluorescence micro-
scope to observe the experiments in real-time. Depending 
on the observed outcome of a particular experiment, we are 
able to automatically adjust the current experimental setup. 
Thus, for the first time to our knowledge, conditional expe-
riments can be performed. 
ProCell can be viewed as an ASPLoC as it can be used to 
implement a specific set of applications with reasonably 
high efficiency, e.g., in vitro drug testing, genomics, stem 
cell analysis, tissue engineering [15]. This would offer the 
possibility of breakthroughs in regenerative medicine, 
cancer research and developmental biology.  
Biochips belong to the class of Micro-Electro-Mechanical 
Systems (MEMS) and exhibit many different types of 
faults. Modeling these faults and their impact is imperative 
in order to perform a realistic system analysis.  
In this paper we propose a biochip architecture model and 
a comprehensive fault model. We model faults that cause 
partial failures in the chip during operation and propose a 
success metric Q , which provides a qualitative measure of 
the chip performance in the presence of partial failures. 
Using the proposed simulation framework, we provide an 
architectural-level comparison of two cell culture chamber 
implementations. Our results show that significant im-
provements in efficiency can be obtained using redundancy, 
providing improved chances to complete an experiment 
even in the presence of faults. This decreases the experi-
ment repetition rate while increasing system productivity, 
saving time (one cell culture experiment can take many 
days to complete), and reducing costs, since the purified 
proteins and compounds used in the experiments are highly 
expensive.  
 The rest of the paper is organized as follows. Section II 
describes the details of the ProCell prototype operation. 
Section III.A presents the architecture model of the cell 
culture biochip and Section III.B gives details of the pro-
posed fault model. Different redundancy schemes are dis-
cussed in Section III.C and Section III.D gives out the 
problem formulation. The simulation framework is pre-
sented in Section IV. Section V describes the experimental 
results and Section VI presents the conclusions. 
II. PROCELL PROTOTYPE OPERATION 
ProCell is a new microfluidic-based device (being devel-
oped at the Technical University of Denmark, DTU) for 
culturing and monitoring of living cells in real-time [15]. 
ProCell is aimed to be a powerful, user-programmable, 
completely self-contained open platform for performing 
high throughput conditional cell culture experiments.  
The ProCell chip contains one large chamber with 16 in-
lets and 16 outlets. There are a total of 32 individual inlets 
carrying soluble compounds (e.g., growth factors), which 
connect to the chamber inputs through 16 independent two-
way valves. ProCell cell culture chamber is a modified 
version of the well characterized single experiment culture 
chamber developed at DTU [16]. Fig. 1 shows an example 
of a large chamber being divided into 8 virtual cell culture 
chambers using the laminar flow property of liquids at 
micro scales (each row can be viewed as a virtual chamber). 
Laminar flow is a distinguished category in the liquid flow 
classification [3]. Laminar flows are defined as the flow of 
fluids in parallel layers without any disruption between the 
layers. To carry out the experiment, first, valve D2 is 
opened and valve D1 is closed, allowing 8 different cell 
types to be pumped into the large chamber and since lami-
nar flow conditions are applied eight corresponding stripes 
of cells are produced. After sedimentation, cells adhere to 
the bottom of the chip.  
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Figure 1: ProCell: Laminar flow-based large chamber 
 
Then, valve D2 is closed and valve D1 is opened, allow-
ing eight soluble compounds to perfuse over the cells in the 
perpendicular direction creating simultaneous experiments 
in the chip. Exposure of a cell colony to the soluble com-
pound and monitoring its reaction is termed as an experi-
ment. Since we have 8 cell colonies in each virtual chamber 
and there are 8 virtual chambers in total, thus we have 64 
simultaneous experiments taking place in the chip. The fluid 
flow is managed by pumps that are controlled by electric 
motors.  
 A.  Large Chamber vs Isolated Chambers  
Fig. 1 shows a large chamber that is divided into 8 virtual 
chambers. Each chamber holds 8 cell colonies. Dividing the 
large chamber in such a way allows the in vitro conditions 
in the virtual chambers to resemble more closely to the 
natural in vivo conditions, since the cells are placed next to 
each other both horizontally as well as vertically.  
A second choice of chamber architecture is to use 8 inde-
pendent chambers physically isolated from each other. Just 
like the virtual chambers in the previous case, each isolated 
chamber also holds 8 cell colonies. The difference in this 
case is that the cells are placed next to each other only 
horizontally. Vertically, the isolated chambers have solid 
boundaries, i.e., each row (representing a chamber) is 
isolated from the rows next to it. Although such a scheme 
may have less resemblance with the natural conditions, it 
may prevent faults in one chamber, such as air bubbles, 
from advancing to the other chambers. We analyze the 
performance of both kinds of chamber implementations in 
this paper. 
B.  Conditional Experiments  
The current ProCell prototype is able to run up to 64 ex-
periments simultaneously. We use an inverted fluorescence 
microscope to observe the experiments in real-time,  allow-
 
Figure 2: Biochip Architecture Model 
 
ing kinetic data analysis. Depending on the observed inter-
mediate outcome of a particular experiment through optical 
feedback, we are able to automatically adjust the current 
experimental setup thus creating conditional experiments.  
ProCell uses the Zeiss AxioObserver Z1 inverted fluores-
cence microscope [19] for real time image capturing of the 
cell culture chamber over extended periods of time. The 
microscope is integrated with a Fujitsu high-end worksta-
tion CELSIUS R650. MCL-D2568 [20].  
III. SYSTEM MODEL 
A.  Biochip Architecture Model 
Fig. 2 shows the biochip architecture model. Each row in 
the model represents a chamber1. The architecture is 
represented by an 8x8 matrix (8 rows representing 8 cham-
bers, where each chamber hosts 8 cell colonies). Each 
element of the 8x8 matrix hosts a cell colony, i.e., a separate 
experiment. 2 
One primary step common to all cell culturing applica-
tions is the placement of cell colonies onto the chambers. In 
Fig. 2, 20 different cell colonies (C1 – C20) are placed on the 
biochip. The cell colonies marked with different patterns 
represent the fault affected regions, see next section. Each 
cell culture experiment requires some sort of controls to 
ensure quality of compounds being inserted into the cham-
ber (which may degrade over time since one experiment 
lasts for many days) and to guarantee that the conditions in 
the chamber (e.g., a certain compound concentration) are 
uniform (some cell colonies might consume the compound 
at a rate fast enough to deprive the cell colonies downstream 
of it, creating undesired non-uniform conditions). Positive 
and negative controls, provided by specific cell colonies 
depending on the application, are used for this purpose [17]. 
Cell colonies serving as positive controls are manipulated to 
give out positive signals (e.g., certain level of fluorescence) 
in the presence of desired conditions (e.g., desired concen-
tration of the compound) and are placed as the last cell 
colony in the chamber as shown in Fig. 2 using notation C+. 
Absence of a positive signal from a positive control means 
                                                 
12In the rest of the paper, the chamber will be used interchangeably for the 
virtual or isolated chamber (not for the large chamber). 
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that the chamber no longer holds the desired conditions and 
the experimental results of that chamber are no longer 
reliable. Cell colonies serving as negative controls are 
manipulated to give out negative signals (e.g., absence of a 
certain level of fluorescence) in the presence of desired 
conditions (e.g., desired quality/ concentration of the com-
pound) and are placed as the first cell colony in the chamber 
as shown in Fig. 2 using notation C–. A negative control 
giving positive results also renders the chamber experimen-
tal results unreliable.  
Different cell colonies can exhibit different properties in a 
chip and are thus placed at different locations in the cham-
ber, based on the application. Some cell colonies (termed as 
Comm – communicator colonies) secrete compounds that 
are useful for the cell colonies placed downstream. Such 
colonies are placed close to the chamber inlets. It may also 
be possible that these secretions are instead harmful for the 
other cell colonies, in which case the cell colonies secreting 
these compounds are placed close to the outlets ensuring 
that they do not contaminate the chamber. Some cell colo-
nies might be very rare or very expensive (and thus are 
considered high priority – HP) and would hence be placed 
at the location most suited to their requirements, making a 
compromise on the placement of other cell colonies (consi-
dered low priority – LP). HP and LP can also reflect the 
weight of a particular combination of cells and experimental 
conditions in a chamber, since some combinations may be 
more vital than others in order to test a certain hypothesis. 
The cell colony placement scheme (the order in which the 
colonies are placed) on a chamber is thus dependent on the 
properties of the cell colonies and the desired output of the 
experiments being run on the chip. Placement scheme can 
have an impact on the tolerance to faults, e.g., colonies 
placed close to the inlets are more susceptible to air bubbles 
than the ones placed close to the outlets.  
Based on the cell colony properties, the colonies placed 
on the chip in Fig. 2 are categorized as: 
• Negative Control (–): C– 
• Positive Control  (+): C+ 
• Comm:   C2, C6, C12, C17 
• High Priority (HP):            C1, C4, C9, C10, C15 
• Low Priority  (LP): All others 
B.  Fault Model  
As discussed in Section II.B, there are 64 simultaneous 
experiments running on the chip, i.e., each cell colony 
represents a different experiment. Failure of an experiment 
caused by a fault is defined as a cell colony being unable to 
exhibit the reactive response, which it would exhibit other-
wise under the applied conditions in the absence of that 
fault.  
Different kind of faults can occur in a cell culture biochip. 
Some faults (e.g., mechanical pump breakdown, electronic 
motor failure) result in the failure of all the cell colonies in a 
chamber (complete chamber failure), whereas others (e.g., 
air bubbles enclosing one cell colony in the chamber thus 
modifying its conditions) may lead to the failure of some of 
the cell colonies in the chamber, i.e., a partial chamber 
failure. In this paper we model partial failures in the chip 
and propose a metric called Failure Index (FI) which is used 
to provide a qualitative success measure of the biochip 
performance in the presence of partial failures.  
 
TABLE 1 
FAULT TYPES 
 
Cause Fault Error Impact Possible 
Failure 
Grade 
Air 
bubbles 
Cells in 
the 
chamber 
enclosed 
in air 
bubbles 
Cells enclosed in 
air bubbles no 
longer affected 
by the compound 
inserted into the 
chamber 
Complete 
or partial 
chamber 
failure  
 
FC 
C 
PH 
PL 
 
Over-
stressed 
cells 
None or 
partial 
cell 
adhesion 
Some cells in 
some chambers 
flushed out with 
the media 
Complete 
or partial 
chamber 
failure  
FC 
C 
PH 
PL 
Over-
stressed 
cells           
Cells no 
longer 
react in a 
normal 
manner 
None or incorrect 
results which 
will not be 
reproduced upon 
repetition 
Complete 
or partial 
chamber 
failure  
 
FC 
C 
PH 
PL 
 
 
A quantitative measure of success of the biochip can be 
the total number of experiments run on the biochip without 
failure. However, the cell colonies placed on the biochip 
have different properties and failure of one cell colony may 
have a stronger impact compared to the other, e.g., failure of 
the negative control would result in the failure of the whole 
chamber. Thus a qualitative measure of success is required.  
Table 1 presents the three most common faults that occur 
in cell culture biochips together with the corresponding 
errors and possible failure grades. Failure grade assignment 
is done to all 64 cell colonies on the biochip depending on 
the kind and/or number of cell colonies affected by the 
fault. Failure grade PL or PH is assigned if the fault occurs 
on a low priority or a high priority cell colony, respectively. 
If the fault occurs on a communicator colony or on all the 
negative/ positive controls available in a chamber, failure 
grade PH is assigned to all the colonies in the chamber 
marking a complete chamber failure. Failure grade CC is a 
chamber level failure grade marking complete chamber 
failure and FC is a chip level failure grade representing full 
chip failure.  
Table 2 shows the value contributed by the fault type to 
the total Failure Index metric depending on the failure grade 
assigned to the fault. For example, a single PL grade failure 
contributes 1 failure point, whereas a high priority cell 
colony failure resulting in a PH grading contributes 2 
failure points. Failure of the positive or negative controls or 
a communicator colony is ranked as a complete chamber 
failure equivalent to 16 failure points. Last column of 
Table 2 shows the range of PL failure index contribution for 
a chamber as {0-5, 16}. This represents that that if 5 cell 
colonies out of the 6 in a chamber (2 cell colonies are 
reserved for positive and negative controls) undergo partial 
failure, the failure index contribution is 5 points, whereas 
partial failure of all 6 colonies is ranked as a complete 
chamber failure equivalent to 16 failure points. Same ap-
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plies for the failure index contribution of PH failure shown 
in the Table. Using different failure index contributions for 
different impacts allows qualitative evaluation of chip 
failure.  
TABLE 2 
FAILURE INDEX 
 
Fault 
Impact 
Failure 
Grade 
Description Failure Index  
Contribution 
Partial 
Chamber 
Failure  
PL 
3 
Represents partial 
chamber failure, L in PL 
represents failure of low 
priority cells 
1 / Each low 
priority cell 
experiment failure 
in the chamber 
[0 – (M-l-1) 1, 2M] 
PH 
 
Represents partial 
chamber failure, H in 
PH  represents failure of 
high priority cells 
2 / Each high 
priority cell 
experiment failure 
in the chamber 
(0 – 2×(M-l-1), 2M) 
Complete 
Chamber 
Failure 
CC 
 
Represents complete 
failure of a chamber 
(e.g., loss of posi-
tive/negative control or 
the Comm) 
 
 2M 
Full Chip 
Failure 
FC Represents simultane-
ous complete failure of 
all chambers 
 
N1 × 2M 
 
The Failure Index of a chip is calculated by adding the 
failure index contributions (FIC) of all chambers: 
,   
                                   ܨܫ ൌ  ∑ ܨܫܥ݅ே௜ୀଵ                                (1) 
 
where N is the number of chambers. 
 
In order to calculate FIC of a chamber, first the failure 
grade of the fault is determined based on the cell colony 
type at which the fault occurs. Based on the failure grade, 
the FIC for chamber 1 can be calculated as,  
 
                       ܨܫܥଵ ൌ  ඃ∑ ܲܪ݅ ܯ௜ୀଵ ඇ ൅ ڿ∑ ܲܮ݅ ெ௜ୀଵ ۀ                 (2) 
 
where M is the number of cell colonies in the chamber, PH 
represents the failure points contributed by any high priority 
cell failures in the chamber, and PL represents the failure 
points contributed by the low priority cell failures. The roof 
value for the first term is 2M (16 in this case) which is 
applied in case the summation value exceeds (M–l–1), 
where l is the number of cell colonies reserved for the 
positive and negative controls in the chamber. The roof 
value for the second term is also 2M and is applied if the 
summation value exceeds 2×(M–l–1).  
In Fig. 2, chamber 1 (marked with inlet A1) has an air 
bubble failure on C–. Loss of the negative control marks a 
complete chamber failure, thus FIC1 = 16. In chamber 6, 
cell colonies C4 and C8 fail to adhere to the chip and are 
flushed out. C4 and C8 are in categories HP and LP respec-
tively. As per eq. 2, FIC6 is calculated as (2 + 1) = 3.  
                                                 
13N is the maximum number of chambers and M is the maximum number of 
cell colonies per chamber. In this case,   N = M = 8. l is the number of colonies 
used for positive and negative controls per chamber, in Fig. 3 l = 2. 
Similarly, FIC2, FIC3, FIC4, and FIC8 are equal to 16. FIC5 
and FIC7 are equal to 0. Failure Index of the whole chip is 
equal to sum of all FIC (1), i.e., 83 for this case. In the 
worst-case, FI is represented by a full chip failure (FC in 
Table 2).  
The success metric Q  is thus calculated as, 
  
                      Q  ൌ ቂே ൈ ଶெି ிூே ൈ ଶெ ቃ ൈ 100                             (3) 
 
where N and M represent the number of chambers and the 
number of cell colonies in a chamber, respectively. For the 
current case, Q  is (128 – 83) / 128 =  35.15%. 
Note that chamber 6 and chamber 7 in Fig. 2 have the 
same placement scheme. Chamber 6 is affected with partial 
failures, whereas chamber 7 is fault free. The redundancy 
increases the success probability for that particular place-
ment scheme. The redundancy schemes are discussed in the 
next section. 
The faults listed here are permanent faults that occur dur-
ing chip operation and are detected through optical feedback 
in real time. Based on the detection results, the experimental 
setup is adjusted to cater for the caused errors. Fault detec-
tion is not a part of the ProCell simulator since the faults are 
randomly generated and injected into the cell culture cham-
ber during simulation. The simulator is used to architectu-
rally compare two different cell culture chamber implemen-
tations.   
C.  Redundancy Schemes 
Different redundancy schemes can be introduced into the 
chambers in order to improve the chip reliability. Two types 
of redundancy schemes are proposed here: placement re-
dundancy and control redundancy.  
Placement redundancy is defined as placement of the 
same cell colonies in multiple chambers, i.e., the colony 
placement done in one chamber is repeated in multiple 
chambers. The number of chambers in which the same 
placement is repeated is termed as the redundancy level.  
In this paper, two types of chamber implementations are 
under consideration as discussed in Section II.A. The prima-
ry difference between the two implementations, in terms of 
fault impact, is that in the virtual chambers (present in one 
large chamber) the air bubbles can easily spread from one 
chamber to the other.  
 
                         Level = 2                Level = 4                Level = 8 
Figure 3: Placement Redundancy: 8 Isolated Chambers 
 
 
            Level = 2              Level = 3               Level = 4              Level = 8 
Figure 4: Placement Redundancy: Large Chamber (8 Virtual Chambers) 
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However, this is not true for the isolated chambers since 
those are separated from each other using solid boundaries. 
Fig. 3 shows the placement redundancy schemes for the 
isolated chambers implementation. Fig. 4 shows the place-
ment redundancy schemes for the virtual chambers. Maxi-
mum air bubble radius is set to three chambers. For redun-
dancy levels 1 and 2 in Fig. 4, the redundant placements are 
made 2 chambers apart such that the air bubble affecting 
one chamber does not affect the other redundant chambers 
even in the worst-case.  
Control redundancy is defined as placing multiple control 
colonies on a single chamber, e.g., instead of one negative 
control two negative controls can be placed on the chamber. 
Failure of the control marks the failure of the whole cham-
ber. Thus, the placement of redundant controls can increase 
the success probability of the experiment.  
D.  Problem Formulation  
The problem addressed can be formulated as follows. 
Given (1) a cell culture biochip architecture model M 
consisting of an N × M matrix representing the cell culture 
chamber, (2) a set of three different static cell colony 
placement schemes P, (3) a fault model F together with the 
set of occurrence rates of different faults, and (4) a set of 
placement redundancy levels R , the target is to perform an 
architectural level evaluation of two implementations: large 
chamber (with virtual chambers) vs isolated chambers.  The 
evaluation provides qualitative measure of success Q for 
each chamber implementation under the same conditions. 
The evaluation is made at different redundancy levels in 
both cell culture chamber implementations in order to 
determine the variation in Q . 
The architectural evaluation involves mapping the place-
ments P onto the chamber architecture model, conducting a 
property analysis of the placed cell colonies, randomly 
generating different faults according to the given occurrence 
rates (see Section V for details) and calculating the failure 
index FI which is used to calculate Q. The performance 
evaluation is based on the properties of the architecture 
model, the fault model and the cell colonies at which these 
faults occur. The architectural comparison is performed 
independent of any specific application rendering the results 
equally applicable to all applications that can be executed 
on the chip.  
IV. PROCELL SIMULATOR 
The simulation framework is shown in Fig. 5. Cell cham-
ber implementation choice, the placement scheme, fault 
rates and selected redundancy levels are given as an input to 
the simulator.  
The first step in the simulator operation is to map the se-
lected placement onto the selected chamber implementation. 
The chamber implementation is represented as a matrix 
model in the simulator. Different cell colonies have differ-
ent properties and thus different priority levels as discussed 
in  Section III.A. Based on the  properties of these cell colo- 
 
Figure 5: Simulation Framework 
 
nies, a new property matrix is generated next. This property 
matrix is utilized at the time of failure index evaluation 
since the same fault occurring on cell colonies with differ-
ent properties can result in a different failure index contri-
bution. 
Next, using Monte Carlo Simulation (MCS), faults are 
randomly generated based on the chosen fault rates and 
evaluated to generate the Failure Index (FI) and the success 
metric Q . FI calculation takes into account the fault model 
built in the simulator, the generated property matrix, se-
lected chamber implementation and the chosen redundancy 
level. At the end of the MCS cycle (10,000 runs), the aver-
age percentage value of Q is calculated and generated as an 
output.  
Next, using Monte Carlo Simulation (MCS), faults are 
randomly generated based on the chosen fault rates and 
evaluated to generate the Failure Index (FI) and the success 
metric Q . FI calculation takes into account the fault model 
built in the simulator, the generated property matrix, se-
lected chamber implementation and the chosen redundancy 
level. At the end of the MCS cycle (10,000 runs), the aver-
age percentage value of Q is calculated and generated as an 
output.  
V. EXPERIMENTAL RESULTS 
Table 3 shows the results of the architectural comparison 
(as a measure of Q) between the two chamber implementa-
tions using varying fault rates. Only control redundancy is 
utilized for this comparison. The property based description 
of the three placement schemes is as follows: 
 
 P1 =  < –, Comm, LP,       LP, LP, LP,  LP, + >  
 P2 =  < –, Comm, LP, Comm, LP, LP,  HP, + >  
 P3 =  < –,     –     , LP, Comm, LP, LP, HP, + >  
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TABLE 3 
RESULTS: PERFORMANCE COMPARISON 
 
Fault Rate P1 P2 P3 
8 Isolated chambers 
(10,5,5) 55.14 54.19 58.53 
(20,5,5) 38.08 36.72 41.26 
8 virtual chambers 
(Max air bubble radius = 3 chambers) 
(10,5,5) 44.25 43.15 48.02 
(20,5,5) 23.30 21.58 25.66 
8 virtual chambers 
(Max Air bubble radius = 5 chambers) 
(10,5,5) 36.36 34.96 39.96 
(20,5,5) 15.27 13.93 17.52 
 
TABLE 4 
8 ISOLATED CHAMBERS: REDUNDANCY RESULTS 
 
Fault Rate Redundancy P1 P2 P3 
(10,5,5) 2 79.60 71.40 81.09 
(20,10,10) 2 46.30 32.80 47.11 
(30,15,15) 2 22.97 12.47 23.61 
(40,20,20) 2 10.33 4.25 10.50 
(10,5,5) 4 95.14 91.37 95.86 
(20,10,10) 4 69.86 54.16 71.24 
(30,15,15) 4 40.07 23.41 41.37 
(40,20,20) 4 18.93 7.89 19.31 
(50,25,25) 4 7.75 2.25 7.92 
(10,5,5) 8 99.27 98.80 99.60 
(20,10,10) 8 88.38 78.15 90.01 
(30,15,15) 8 62.53 40.96 64.06 
(40,20,20) 8 33.47 15.25 34.75 
(50,25,25) 8 14.66 4.50 15.19 
 
TABLE 5 
8 VIRTUAL CHAMBERS: REDUNDANCY RESULTS 
 
Fault Rate Redundancy P1 P2 P3 
Maximum air bubble radius is 3 chambers for all cases
(10,5,5) 2 74.46 64.55 75.90 
(20,10,10) 2 37.53 24.69 38.26 
(30,15,15) 2 16.49 8.13 16.92 
(40,20,20) 2 6.45 2.4 6.67 
(10,5,5) 3 83.19 74.20 84.87 
(20,10,10) 3 43.54 28.33 44.44 
(30,15,15) 3 18.45 8.83 19.10 
(40,20,20) 3 7.00 2.46 7.20 
(10,5,5) 4 87.41 79.75 89.27 
(20,10,10) 4 49.08 32.33 50.57 
(30,15,15) 4 21.06 9.89 21.59 
(40,20,20) 4 7.70 2.61 13.64 
(10,5,5) 8 95.82 92.41 96.71 
(20,10,10) 8 66.87 49.16 69.58 
(30,15,15) 8 33.33 16.71 35.02 
(40,20,20) 8 12.85 4.36 13.67 
(50,25,25) 8 4.23 0.97 4.50 
 
As can be seen, P2 and P3 are identical, other than the 
fact that the Comm of P2 is replaced by an extra negative 
control in P3, providing the control redundancy.  
Different fault rates can be chosen for the three types of 
faults discussed in Table 1. Fault rates under which the 
simulation experiments were performed are given in the 
first column in Table 3. Since no statistics on the fault 
occurrence rates are available yet, we base our experiments 
on the limited observations made during the ProCell opera-
tion. The experiments are carried out at different fault rates 
per experiment and the results are analyzed. Whenever 
more accurate statistics become available, those can easily 
be plugged into the simulator to perform architectural 
evaluation. The notation (10, 5, 5) in the first column of the 
Table means that the air bubble occurrence rate is 10%, rate 
of the faults resulting in cells not adhering to the chamber is 
5% and the rate at which the cells become non-reactive is 
5%, respectively.  
Since the air bubbles are inserted into the chamber 
through inlets, the cell colonies closer to the inlets are more 
susceptible to the air bubble faults than the ones close to the 
outlets. We assume a linear decrease of 1% in the occur-
rence rate when moving from the inlets to the outlets in the 
chamber, i.e., cell colony closest to the inlet has a rate of 
10%, next one has a rate of 9%, and so on.  
As shown in Table 3, the isolated chambers have a higher 
success rate Q compared to the virtual chambers. As the 
fault rates increase, the gap in the success metric also wi-
dens. This is because in the virtual chambers the air bubbles 
can easily spread from one chamber to the other. However, 
this is not true for the isolated chambers since those are 
separated from each other using solid boundaries. Compar-
ing results of P2 and P3, it can be seen that the control 
redundancy provides up to 5% increase in Q. Tables 4 and 5 
show the variations in Q as a result of placement redundan-
cies for the same placement schemes. 
As shown in Table 4, even a level-2 placement redundan-
cy provides up to 24% increase in Q (P1 under (10, 5, 5)) 
compared to the results without placement redundancy in 
Table 3 for isolated chambers. Q is calculated by using the 
average Q calculated over an MCS cycle (10,000 runs). For 
every run, the higher value of Q from the two redundant 
chambers (for level-2) is considered for calculating the 
average Q . The redundancy level can be increased to cater 
for the increasing fault rates. However, for the isolated 
chambers as shown in Table 4, the Q  value falls below 35% 
when the fault rates go up to (40, 20, 20), even with a 
placement redundancy level of 8. For the virtual chambers, 
the results are shown in Table 5. At the placement redun-
dancy level 8, Q  goes as low as 35% at the fault rates (30, 
15, 15).  
The results show that the mixed redundancy scheme (both 
placement and control) provides the best results. 
VI. CONCLUSION 
In this paper we have presented a modeling and simula-
tion framework for the cell culture microfluidic biochip 
ProCell. We have proposed a biochip architecture model 
and a comprehensive fault model capturing permanent 
faults that occur during the chip operation. Using the pro-
posed simulation framework, we have carried out an archi-
tectural level evaluation of two cell culture chamber imple-
mentations. The proposed approach considers the fault 
model, cell placement scheme, fault occurrence rates, and 
the redundancy level and provides a qualitative success 
metric as a measure of performance for both architectures in 
the presence of partial failures. Three different cell place-
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ment schemes have been used to evaluate the architectural 
performance under different redundancy levels and varying 
fault rates.  Our results show that significant improvements 
in efficiency can be obtained by using redundancy schemes; 
increasing the system productivity, saving time and reduc-
ing costs. However, evaluation depicts that both architec-
tures have separate limits of maximum tolerable fault rates, 
after which the redundancy is no longer effective in improv-
ing the chip performance.  
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